In Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
66
- Portfolio
-
41
- Exits
-
17
In Capital General Information
Company Description
Founded in 2015, In Capital is a venture capital firm based in Beijing, China. The firm seeks to invest in medical services, medical instruments, biomedicine, vitro diagnosis and smart medical devices, including artificial intelligence, big data, internet of things and robots sectors based in China.
Business Details
Website
www.in-capital.cnYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Rm 3005, Sunshine Financial Center, Number 33 Jinghui Avenue
- Chaoyang District
- Beijing
- China
In Capital Investments (66)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Rhino Health (Surgical Devices) | 05-Nov-2026 | Later Stage VC | Surgical Devices | Generating Revenue | ||
| Hyperway (Drug Discovery) | 30-Sep-2026 | Drug Discovery | Generating Revenue | |||
| CoreRhythm Medical Technology | 16-Sep-2026 | Monitoring Equipment | Generating Revenue | |||
| Kossel Medtech | 01-Sep-2026 | Therapeutic Devices | Generating Revenue | |||
| DeliNova Therapeutics | 10-Jun-2026 | Drug Discovery | Generating Revenue | |||
| Kind Pharmaceutical | 20-Apr-2026 | Drug Discovery | Generating Revenue | |||
| Immunofoco Biotechnology | 09-Feb-2026 | Drug Discovery | Generating Revenue | |||
| Sandt Inspection | 24-Oct-2025 | Diagnostic Equipment | Generating Revenue | |||
| Zenshine Pharmaceuticals (Nanjing) Group | 25-Mar-2025 | Later Stage VC | Drug Discovery | Profitable | ||
| Zenshine Pharmaceuticals (Nanjing) Group | 17-Jan-2025 | Secondary Transaction - Private | Drug Discovery | Profitable |
In Capital Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| HEXANIKA | 01-Apr-2026 | Secondary Transaction - Private | |
| Desty | 27-Aug-2025 | ||
| SS Innovations | 25-Apr-2025 | ||
| ZD Medical | 21-Feb-2023 | ||
| Canopus Medical | 30-Nov-2022 | ||
| Asieris Pharmaceuticals | 07-Jan-2022 | ||
| Hanyu Medical | 23-Nov-2020 | ||
| Genetron Health | 15-Jun-2020 | ||
| Blue Ocean Strategy (China) | 11-Oct-2019 | Out of Business | |
| Kareway Health | 25-Sep-2018 | Buyout/LBO |
In Capital Investments by Industry, Year, and Region
In Capital Co-Investors (55)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Gaorong Ventures | 2 |
|
|
||
| Proxima Capital |
|
|
|||
| Legend Capital |
|
|
|||
| SB China Venture Capital |
|
|
|||
| Shenzhen Capital Group |
|
|
In Capital FAQs
-
What is In Capital?
Founded in 2015, In Capital is a venture capital firm based in Beijing, China.
-
When was In Capital founded?
In Capital was founded in 2015.
-
Where is In Capital headquartered?
In Capital is headquartered in Beijing, China.
-
How many investments has In Capital made?
In Capital has made 66 investments.
-
What has In Capital invested in?
In Capital has made numerous investments in companies like Rhino Health (Surgical Devices), Hyperway (Drug Discovery), and CoreRhythm Medical Technology within the Surgical Devices, Drug Discovery, and Monitoring Equipment industries.
-
What has In Capital invested in recently?
In Capital's latest investment was on 05-Nov-2026 in Rhino Health (Surgical Devices), a company within the Surgical Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process